<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149495/" ref="ordinalpos=4305&amp;ncbi_uid=6555383&amp;link_uid=PMC4149495" image-link="/pmc/articles/PMC4149495/figure/pone-0105792-g001/" class="imagepopup">Figure 1. Schematic representation of a network of PI3K, mTOR and MEK complex <span class="highlight" style="background-color:">signaling</span>..  From: Relationships between <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> Usage and Sensitivity to a <span class="highlight" style="background-color:">Pathway</span> Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines. </a></div><br /><div class="p4l_captionBody">Blue arrows and black lines represent activating and inhibitory connections, respectively.</div></div>